Exaggerated Neointima Formation in Human C-reactive Protein Transgenic Mice is IgG Fc Receptor Type I (Fc Gamma RI)-dependent

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2007 Dec 8

PMID 18063701

Citations 25

Authors

Dongqi Xing

Fadi G Hage

Yiu-Fai Chen

Mark A McCrory

Wenguang Feng

Gregory A Skibinski

Erum Majid-Hassan

Suzanne Oparil

Alexander J Szalai

Affiliations

Soon will be listed here.

Abstract

Neointima formation after vascular injury is exaggerated in ovariectomized (OVX) human C-reactive protein transgenic mice (CRPtg) compared to nontransgenic mice (NTG). We tested the hypothesis that this CRP-mediated exacerbation requires IgG Fc receptors (Fc gamma Rs). OVX NTG, CRPtg, and CRPtg lacking Fc gamma RI, Fc gamma RIIb, Fc gamma RIII, or the common gamma chain (FcR gamma) had their common carotid artery ligated. Twenty-eight days later neointimal thickening in CRPtg/Fc gamma RI(-/-) and CRPtg/FcR gamma (-/-) was significantly less than in CRPtg and no worse than in NTG, whereas in CRPtg/Fc gamma RIIb(-/-) and CRPtg/Fc gamma RIII(-/-) neointimal thickness was equal to or greater than in CRPtg. Immunohistochemistry revealed human CRP in the neointima of CRPtg, but little or none was observed in those lacking Fc gamma RI or FcR gamma. Real-time reverse transcriptase-polymerase chain reaction demonstrated that Fc gamma R types I to III were expressed in the CRPtg arteries, with Fc gamma RI expression increasing by threefold after ligation injury. Levels of serum complement (C3), neointimal deposition of complement (C3d), and cellular composition (monocytes, macrophages, lymphocytes) in the neointima did not differ among the different CRPtg genotypes. However, by immunofluorescence a neointimal population of F4/80+CRP+ cells was revealed only in OVX CRPtg. The exaggerated response to vascular injury provoked by CRP in OVX CRPtg depends on Fc gamma RI and probably requires its expression by F4/80+ cells.

Citing Articles

C-reactive protein: a target for therapy to reduce inflammation.

Rizo-Tellez S, Sekheri M, Filep J Front Immunol. 2023; 14:1237729.

PMID: 37564640 PMC: 10410079. DOI: 10.3389/fimmu.2023.1237729.

Identification of key differential genes in intimal hyperplasia induced by left carotid artery ligation.

Zhang L, Gu J, Wang S, He F, Gong K PeerJ. 2022; 10:e13436.

PMID: 35586138 PMC: 9109685. DOI: 10.7717/peerj.13436.

The Effect of Race and Shear Stress on CRP-Induced Responses in Endothelial Cells.

Ling C, Cook M, Grimm H, Aldokhayyil M, Gomez D, Brown M Mediators Inflamm. 2021; 2021:6687250.

PMID: 34899053 PMC: 8660250. DOI: 10.1155/2021/6687250.

Therapeutic Lowering of C-Reactive Protein.

Jimenez R, Szalai A Front Immunol. 2021; 11:619564.

PMID: 33633738 PMC: 7901964. DOI: 10.3389/fimmu.2020.619564.

Recent advances into the role of pattern recognition receptors in transplantation.

Kulkarni H, Scozzi D, Gelman A Cell Immunol. 2020; 351:104088.

PMID: 32183988 PMC: 7170002. DOI: 10.1016/j.cellimm.2020.104088.

References

Agrawal A, Shrive A, Greenhough T, Volanakis J . Topology and structure of the C1q-binding site on C-reactive protein. J Immunol. 2001; 166(6):3998-4004. DOI: 10.4049/jimmunol.166.6.3998. View

Schmeisser A, Garlichs C, Zhang H, Eskafi S, Graffy C, Ludwig J . Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res. 2001; 49(3):671-80. DOI: 10.1016/s0008-6363(00)00270-4. View

Krupinski J, Turu M, Martinez-Gonzalez J, Carvajal A, Juan-Babot J, Iborra E . Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke. 2006; 37(5):1200-4. DOI: 10.1161/01.STR.0000217386.37107.be. View

Murphy C, Beckers J, Ruther U . Regulation of the human C-reactive protein gene in transgenic mice. J Biol Chem. 1995; 270(2):704-8. DOI: 10.1074/jbc.270.2.704. View

Heuertz R, Schneider G, Potempa L, Webster R . Native and modified C-reactive protein bind different receptors on human neutrophils. Int J Biochem Cell Biol. 2004; 37(2):320-35. DOI: 10.1016/j.biocel.2004.07.002. View

Danenberg H, Szalai A, Swaminathan R, Peng L, Chen Z, Seifert P . Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation. 2003; 108(5):512-5. DOI: 10.1161/01.CIR.0000085568.13915.1E. View

Takai T, Li M, Sylvestre D, Clynes R, Ravetch J . FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 1994; 76(3):519-29. DOI: 10.1016/0092-8674(94)90115-5. View

Wang D, Oparil S, Chen Y, McCrory M, Skibinski G, Feng W . Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol. 2005; 25(10):2094-9. DOI: 10.1161/01.ATV.0000179602.85797.3f. View

Pasceri V, Willerson J, Yeh E . Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000; 102(18):2165-8. DOI: 10.1161/01.cir.102.18.2165. View

10.

Nimmerjahn F, Ravetch J . Fcgamma receptors: old friends and new family members. Immunity. 2006; 24(1):19-28. DOI: 10.1016/j.immuni.2005.11.010. View

11.

Fernandez Pujol B, Lucibello F, Gehling U, Lindemann K, Weidner N, Zuzarte M . Endothelial-like cells derived from human CD14 positive monocytes. Differentiation. 2000; 65(5):287-300. DOI: 10.1046/j.1432-0436.2000.6550287.x. View

12.

Haider D, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L . C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clin Exp Immunol. 2006; 146(3):533-9. PMC: 1810406. DOI: 10.1111/j.1365-2249.2006.03224.x. View

13.

Devaraj S, Du Clos T, Jialal I . Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol. 2005; 25(7):1359-63. DOI: 10.1161/01.ATV.0000168573.10844.ae. View

14.

Paul A, Ko K, Li L, Yechoor V, McCrory M, Szalai A . C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004; 109(5):647-55. DOI: 10.1161/01.CIR.0000114526.50618.24. View

15.

Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T . Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood. 2001; 97(3):785-91. DOI: 10.1182/blood.v97.3.785. View

16.

Verma S, Li S, Badiwala M, Weisel R, Fedak P, Li R . Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002; 105(16):1890-6. DOI: 10.1161/01.cir.0000015126.83143.b4. View

17.

Bodmer B, SIBOO R . Isolation of mouse C-reactive protein from liver and serum. J Immunol. 1977; 118(3):1086-9. View

18.

Bharadwaj D, Stein M, Volzer M, Mold C, Du Clos T . The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med. 1999; 190(4):585-90. PMC: 2195602. DOI: 10.1084/jem.190.4.585. View

19.

Scirica B, Morrow D . Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation. 2006; 113(17):2128-34. DOI: 10.1161/CIRCULATIONAHA.105.611350. View

20.

Han C, Campbell G, Campbell J . Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res. 2001; 38(2):113-9. DOI: 10.1159/000051038. View